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Nonadherence (noncompliance) to drug therapy can
result in increased rates of relapse, morbidity, and mor-
tality. Its overall economic impact has been estimated at
$8 billion annually in Canada, and $80 billion in the US,
including both direct and indirect costs. OBJECTIVES:
The purpose of this study was to estimate the economic
burden of hospital admissions due to patient nonadher-
ence in Canada from the viewpoint of the provincial min-
istries of health. METHODS: We estimated the overall
burden in two steps, using a modeling approach. First,
we estimated the impact of nonadherence on hospital
admissions. We performed a random-effects meta-analy-
sis of the published literature to derive an average rate of
hospital admissions due to nonadherence. We then quan-
tiﬁed the resources in monetary terms in Canadian dollars
(CAD). We used utilization and costing data from Statis-
tics Canada on hospitalizations. Various sensitivity analy-
ses were performed with different costing sources for
hospitalizations, such as the Ontario Case Cost Project
and the Ontario Hospital Statistics. RESULTS: We
included 15 studies on nonadherence related hospital
admissions, with a total of 6,144 subjects, to derive an
overall meta-analytic average admission rate of 5.4% (SE
= 0.8%), and 5.2% (SE = 1.1%) for medication under-
use. Applying an average length of stay of 10 days for
10,272 hospital separations per 100,000 population in
Canada, we estimated the 5.4% assumed to be due to
nonadherence to amount to CAD $1,018 million annu-
ally. Sensitivity analysis results ranged from CAD $678
million to CAD $1,633 million annually. CONCLU-
SION: Our results illustrate the extent of the economic
burden of hospitalization due to nonadherence in
Canada. Further studies are warranted for estimating
overall resource use and productivity loss due to 
nonadherence.
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HEALTH EXPENDITURE FOR THE DURATION
OF LAST YEAR OF LIFE IN TAIWAN
Liang LY, Lan CF
National Yang-Ming University,Taipei,Taiwan
OBJECTIVE: The evidenced-based study tests the
hypotheses (i) National Health Insurance Expenditure
increases with closeness to death (ii) National Health
Insurance Expenditure decreases with age. This study
analysis age, sex and health expenditure differences
before the day of death for one-year period during 1999
and 2000. METHODS: In Taiwan the National Health
Insurance Program had covered 97% population. The
claim data were obtained from Bureau of National Health
Insurance (in 1999 and 2000), the vital registration data
(in 2000) were from Department of Health in Taiwan.
Use the vital registration ID number to merge the
National Health Insurance Expenditure, then retrospect
1 day, 2–7 days, 8–14 days, 15–30 days, 31–60 days,
61–90 days, 91–180 days, 181–270 days, and 271–365
days before dying. RESULTS: The 22.1% dead people
had no medical expenditure in the last year of life. The
expenditure of last year of life accounts for 12.8% of all
National Health Insurance Expenditure, 2.6% of it on
ambulatory care, (1.1% for female, 1.5% for male), and
10.3% of it on inpatient care (3.9% for female, 6.39%
for male), respectively. The expenditure 91–180 days
before death accounts for 18.1% (highest) total expendi-
ture of the last year of life, the lowest is 1 day before
death accounts for 2.3%. The total expenditure for the
age groups 0–64, 65–84, and 85+ accounts for 36.5%,
54.2% and 9.3%, respectively. The total expenditure
ascending with age from 27 years-old (0.11%) to 76
years-old (3.3%) then decreasing with each age. But the
last year expenditure proportion to all year expenditure
is ascending from 27 years old with age. The average
expenditure is $8,307 US dollars per decedents, 26.1
times for average expenditure for each person.
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OBJECTIVES: Guidelines for costing of health services
recommend the use of costs of several providers in
forming a variable used to measure unit cost. In the 
Canadian national list of provincial costs hospital costs
were aggregated by all hospitals within each province and
were compared between provinces. In this paper we val-
idate the provincial cost measure, using data from 
Manitoba hospitals. METHOD: The conceptual measure
for our analysisis the Cost per Weighted case (CWC),
which is equal to the total inpatient costs divided by total
weighted cases. The actual (published) measure of CWC
was not audited for standardization; it was compared
with a revised measure, which was adjusted following an
assessment exercise. The revised measure was based on
the following standardization criteria: (1) the measure of
total cost should include all relevant resources used and
appropriately allocated and (2) weighted cases should
reﬂect the year in which costs were measured. Adjust-
ments were made using data from each hospital: inpatient
costs were based on provincially reported costs according
to a Management Information System (MIS) coding
system and weighted cases were based on the Case Mix
Group measure of the Canadian Institute for Health
Information. RESULTS: Of the 38 hospitals reporting
data, 7 (18%) reported a change in CWC of >10%, 16
reported an adjustment of <10%, and 15 reported no
adjustment. The overall change in CWC was substantial:
of those hospitals with conﬁrmed data, the mean adjusted
CWC was $4538 compared with an adjusted value of
$2195. CONCLUSIONS: The large adjustment in CWC
occurred in only a few hospitals, yet it substantially
changed the overall CWC, which would serve as a stan-
dard value for economic studies. It is necessary to vali-
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date individual hospital cost measures in order to ensure
that systemwide costs are comparable and represent
actual resource use.
HEALTH POLICY—Healthcare Information Studies
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commerce). OBJECTIVES: The goal of this study is create
a database of health websites originated from South East
Europe (SEE), and determine the quality of information’s
regarding the customer needs using the World Health
Organization’s (WHO) standard. METHODS: The data-
base, named pluspharma™, was constructed by an 
Internet search and an e-mail questionnaire. The quality
of information was measured according to recommenda-
tion of WHO (a rating of 1 to 5). RESULTS: The data-
base contains about 300 web addresses of useful sources
of health and health business information. Of the six
countries (Bosnia and Herzegovina, Bulgaria, Croatia,
Yugoslavia, Macedonia, Romania), Romania showed the
most (37 public health institutions and 26 public tools
promoting health) Web health information sites. The
most websites originated from the primary health care
institutions, government body or pharmaceutical indus-
try. Also, there is the numerous high quality health 
promotional website designed with speciﬁc task groups
(example tobacco groups). Direct public communication
is evident through about 60% of web sites. Websites of
pharmaceutical industry and pharmacies marking with
relatively high credit (3.89), compared with other health
and service information’s (public and government health
institution). The special task groups (usually evidenced as
NGO) obtained high credit (4.74) of quality and valuable
of Web information’s. CONCLUSIONS: Health-related
websites from South East Europe are becoming good
tools for health promotion in the SEE region.
HEALTH POLICY—Healthcare Study—
Methodology Issues
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THE CONTRIBUTION OF HEALTH ECONOMICS
TO PORTFOLIO MANAGEMENT DECISIONS:A
VACCINE INDUSTRY EXAMPLE
Staginnus U
Baxter, Madrid, Spain
The application of health economics within portfolio
management is not yet widely researched. However,
several studies assume a growing importance of the added
value of health outcomes within early product portfolio
prioritisation in the future. OBJECTIVES: As a ﬁrst step,
to review the current practise in portfolio management
and the most common techniques/parameters used to 
aid internal decision-making. Secondly, to illustrate the
potential impact of the “economic dimension” in strate-
gic development decisions using a vaccine industry
example. METHODS: A MEDLINE search using the
phrases “health/pharmacoeconomics” and/or “portfolio
management” or “early modelling” was conducted. This
search was augmented by additional Internet searches
using various MetaSearch engines. Fifteen papers that
matched the selection criteria were obtained. A simple
Microsoft EXCEL based portfolio assessment tool for
vaccine candidates applying the McKinsey strategy port-
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The Internet is revolutionizing the structure and orienta-
tion of the healthcare market and drug producers, as well.
This new mass media is valuable not only as a source of
information for patients and healthcare providers but 
also as a platform for selling products and services (e-
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